Bifodan A/S   Report issue

For profit Phase 4
Founded: Hundested Denmark (1992)
Status: No NME R&D (1992)

Organization Overview

First Clinical Trial
2019
NCT03843112
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Bifodan A/S

Active Ingredients

Drugs in Phase 4 Trials (2)

lactobacillus gasseri (1 trial)

lactobacillus rhamnosus (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infertility (Phase 4)

Infertility, Female (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2